B. Faivre

发表

Design, synthesis and biological evaluation of new classes of thieno[3,2-d]pyrimidinone and thieno[1,2,3]triazine as inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2).

F. Da Settimo, C. La Motta, S. Sartini, 2013, European journal of medicinal chemistry.

Synthesis and In vivo Studies of Protein C-loaded Nanoparticles with PEO Modified Surfaces

B. Faivre, M. Léonard, J. Six, 2008 .

Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models.

T. Bastogne, M. Barberi-Heyob, B. Faivre, 2012, Trends in biotechnology.

Sensitivity of glioma initiating cells to a monoclonal anti-EGFR antibody therapy under hypoxia.

B. Faivre, C. Boura, S. Pinel, 2015, Life sciences.

Modulation of endothelial cell network formation in vitro by molecular signaling of head and neck squamous cell carcinoma (HNSCC) exposed to cetuximab.

J. Merlin, V. Jouan-Hureaux, B. Faivre, 2012, Microvascular research.

Hemoglobin autooxidation/oxidation mechanisms and methemoglobin prevention or reduction processes in the bloodstream. Literature review and outline of autooxidation reaction.

B. Faivre, P. Menu, C. Vigneron, 1998, Artificial cells, blood substitutes, and immobilization biotechnology.

[Relationship between arterial pressure evolution and free hemoglobin distribution into vascular wall in guinea pigs].

B. Faivre, C. Vigneron, P. Labrude, 2005, Archives des maladies du coeur et des vaisseaux.

Hemoglobin-Based Oxygen Carrier Distribution Inside Vascular Wall and Arterial Pressure Evolution: Is There a Relationship?

B. Faivre, C. Vigneron, P. Labrude, 2005, European Surgical Research.

Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo.

C. Cooper, P. Buehler, Michael T. Wilson, 2006, The Biochemical journal.

Modification of the rat aortic wall during ageing; possible relation with decrease of peptidergic innervation

L. Rochette, B. Faivre, D. Busseuil, 2001, Anatomy and Embryology.

Oxygen binding and oxidation reactions of human hemoglobin conjugated to carboxylate dextran.

A. Alayash, B. Faivre, P. Menu, 2004, Biochimica et biophysica acta.

Rheological behaviour of red blood cells suspended in hemoglobin solutions. In vitro study comparing dextran-benzene-tetra-carboxylate hemoglobin, stroma free hemoglobin and plasma expanders.

D. Longrois, B. Faivre, J. Stoltz, 1999, Transfusion science.

Human hemoglobin conjugated to carboxylate dextran as a potential red blood cell substitute. II--Pharmacotoxicological evaluation.

B. Faivre, P. Menu, C. Vigneron, 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence.

B. Faivre, F. Plénat, C. Boura, 2014, International journal of oncology.

Cellular response to cetuximab in PTEN-silenced head and neck squamous cell carcinoma cell line.

J. Merlin, A. Fifre, A. Chretien, 2010, International journal of oncology.

Contribution de la microscopie electronique a fond noir a l'etablissement du diagramme de transformation des alliages fer-aluminium riches en fer

B. Faivre, L. Rimlinger, 1968 .

Assessment of dextran 10-benzene-tetracarboxylate-hemoglobin, an oxygen carrier, using guinea pig isolated bowel model.

B. Faivre, P. Menu, C. Vigneron, 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

[Blood substitutes: state of the art and technical setbacks and why we are still disappointed].

B. Faivre, C. Vigneron, Y. Smani, 2007, Bulletin de l'Academie nationale de medecine.

Pharmacological and physicochemical factors in the pressor effects of conjugated haemoglobin-based oxygen carriers in vivo

A. Fifre, B. Faivre, C. Vigneron, 2007, Journal of hypertension.

Antiangiogenic therapy: Markers of response, "normalization" and resistance.

B. Faivre, K. El Alaoui-Lasmaili, 2018, Critical reviews in oncology/hematology.

Neuropilin-1 Targeting Photosensitization-Induced Early Stages of Thrombosis via Tissue Factor Release

F. Guillemin, T. Bastogne, M. Barberi-Heyob, 2010, Pharmaceutical Research.

Data-driven modeling and characterization of anti-angiogenic molecule effects on tumoral vascular density

Thierry Bastogne, El-Hadi Djermoune, Jean-Baptiste Tylcz, 2015, Biomed. Signal Process. Control..

Possible importance of chromatographic purification position in a blood substitute elaboration process.

B. Faivre, P. Menu, C. Vigneron, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

A new algorithm for a better characterization and timing of the anti-VEGF vascular effect named “normalization”

E. Djermoune, B. Faivre, Jean-Baptiste Tylcz, 2016, Angiogenesis.

A potential blood substitute from carboxylic dextran and oxyhemoglobin. II. Physicochemical and physiological assessments. Preliminary results on guinea pig.

B. Faivre, E. Dellacherie, P. Menu, 1992, Biomaterials Artificial Cells and Immobilization Biotechnology.

Assessment of histocompatibility of different hemoglobin solutions using mesenteric perfusion on the small bowel of the male Wistar rat.

B. Faivre, C. Vigneron, P. Labrude, 1991, Biomaterials Artificial Cells and Immobilization Biotechnology.

Antiangiogenic therapy: Markers of response, "normalization" and resistance.

B. Faivre, K. El Alaoui-Lasmaili, 2018, Critical reviews in oncology/hematology.

Tumor vascular responses to antivascular and antiangiogenic strategies: looking for suitable models.

T. Bastogne, M. Barberi-Heyob, B. Faivre, 2012, Trends in biotechnology.